This study analyses interest of iv nefopam in combination with paracetamol after major abdominal surgery because the effect of morphine-sparing is discussed when combined these agents.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
The nefopam group received 120 mg nefopam (Acupan, Pharmbio, France) by continuous iv infusion over the study period (48h)
The Control group received 120 mg placebo infusion (saline solution) by continuous iv infusion over the study period (48h).
Estimate morphine consumption
mg
Time frame: over 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.